MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Intellia Therapeutics has dosed the first subject in the Phase III trial of NTLA-2002, to treat hereditary angioedema (HAE).

Mayo Clinic has joined SeaStar Medical as the 15th site authorised to enrol subjects for the company’s pivotal NEUTRALIZE-AKI ...

D-Wave Quantum announces Leap Quantum LaunchPad program to accelerate quantum computing adoption with free trials.

Afrigen Biologics has secured a $6.2m grant from CEPI to develop the first mRNA-based vaccine against Rift Valley fever.

The daughter-in-law of founder Marcel Bich, who perfected the ballpoint pen and launched French company Société Bic in 1945, ...

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

Whatever the time of year, there are always opportunities to improve your health, fitness, and well-being. These gadgets can ...

Four million Australian households and businesses have rooftop solar installed, making us the world leader in the technology.

Two men pleaded not guilty Wednesday to murder and attempted robbery charges stemming from the killing of former “General ...

Towana Looney's vibrant recovery is a morale boost in the quest to make animal-to-human transplants a reality.